Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

(2021) P. Grivas et al.   ANNALS OF ONCOLOGY

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies

(2021) Lee M. Greenberger et al.   CANCER CELL

Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer

(2021) Sidse Ehmsen et al.   CANCER CELL

Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution

(2021) Elizabeth A. Griffiths et al.   CANCER CELL

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

(2021) Ugur Sahin et al.   NATURE

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

(2021) Erin M. Bange et al.   NATURE MEDICINE

COVID-19 and Cancer: Current Challenges and Perspectives

(2020) Ziad Bakouny et al.   CANCER CELL